Health Care/Hospital

Series A financing round lays foundation for international growth of digital cancer therapeutics Mika

New investors with a successful track record in digital oncology support German Digital Therapeutics (DTx) company Fosanis to broaden patient access of Mika – an app-based DTx platform empowering people affected by cancer. BERLIN, LAUSANNE,Switzerland, BARCELONA,Spain and MUNICH, May 9, 2022 /PR...

2022-05-09 19:35 1872

Premix signs $79.9 million contract for a new production facility in the U.S.

The major agreement will help secure critical diagnostic supplies in the United States and better serve Premix's global customers GASTONIA, N.C. and HELSINKI, May 9, 2022 /PRNewswire/ -- The U.S. Department of Defense, working with the Department of Health and Human Services, awarded a $79.9 mill...

2022-05-09 18:35 1331

GLOBAL POLICY WILL REMOVE HEADACHES FROM INTERNATIONAL TRAVEL

Led by Saudi Arabia, the Harmonising Air Travel policy will transform the traveler experience by creating a single, trusted source of information on entry requirements for international travelers  * The global aviation policy has been developed in cooperation with the UN's International Civil ...

2022-05-09 15:30 4108

Singaporeans complete #TheMissingHalf with Reckitt and Shopee

SINGAPORE, May 9, 2022 /PRNewswire/ -- Reckitt, the global leader in health, hygiene and nutrition, partners with Shopee, the leading e-commerce platform in Southeast Asia and Taiwan to launch its "Complete #TheMissingHalf" Regional Super Brand Day. Families can rely on trusted brands from Reckitt...

2022-05-09 14:07 2413

ICA to Host 2nd Annual Asia Pacific Healthcare Conference Online

* ICA continues to host meetings and keynote speeches online to help converge listed companies and investors, as well as capture insights and the recent development trends inAsia's healthcare arena. HONG KONG, May 9, 2022 /PRNewswire/ -- ICA Group Holdings Limited (ICA), anAsia-based leader in ...

2022-05-09 12:30 1908

Manulife appoints Aravind Srinivas as new Chief Risk Officer, Asia

HONG KONG, May 9, 2022 /PRNewswire/ -- Manulife today announced the appointment ofAravind Srinivas as its new Chief Risk Officer, Asia and Head of Global Product and Insurance Risk Management. His appointment is effective9 May 2022.  

2022-05-09 10:35 2666

SCG Cell Therapy announces clinical trial approval of TCR-T cell therapy for liver cancer in Singapore

*SCG101 - autologous T-cell receptor (TCR) T-cell therapy for liver cancer *SCG101 is the first TCR-T cell therapy product to receive a multi-country clinical trial approval from Singapore and China the treatment of HCC *APAC accounts for four in five new cases of liver across globally Singapor...

2022-05-09 10:28 3368

Takeda Malaysia receives coveted HR accolades by creating an exceptional people experience

Key points: * Takeda Malaysia receives Great Place to Work® award for the first time and Top Employer certification for the sixth consecutive year. * A significant majority of employees surveyed in Malaysia in 2021 Great Place to Work® Trust Index stated that Takeda is a great workplace. * ...

2022-05-09 09:05 2077

Takeda Singapore receives coveted HR accolades by creating an exceptional people experience

Key points: * Takeda Singapore receives Great Place to Work® award for the first time and Top Employer certification for the sixth consecutive year. * A significant majority of employees surveyed in Singapore in 2021 Great Place to Work® Trust Index stated that Takeda is a great workplace. ...

2022-05-09 09:00 1806

JW Therapeutics to Present Latest Data of Carteyva® at 2022 ASCO Annual Meeting

SHANGHAI, May 9, 2022 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, announced that it will present the latest clinical study data for Carteyva® via poster pre...

2022-05-09 09:00 2247

ExoCoBio Receives Japanese Patent for Alleviating Dermatitis with Adipose Stem Cell-Derived Exosome

* To lay a technological foundation for developing exosome-based medicines and cosmetic products for dermatitis treatment * To prove the technological feasibility of ExoSCRT™ for the mass-production of the world's best exosomes with high efficacy SEOUL, Korea, May 9, 2022 /PRNewswire/ -- ExoC...

2022-05-09 07:00 3010

Brii Bio Reports Progress on ESG Commitments in Its Inaugural ESG Report

DURHAM, N.C. and BEIJING, May 7, 2022 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company," stock code: 2137.HK), a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health...

2022-05-07 09:00 4821

SICPA AND THE BATAILLON DE MARINS-POMPIERS DE MARSEILLE ARE TESTING AN INNOVATIVE SOLUTION FOR DETECTING PATHOGENS IN AIRCRAFT WASTEWATER

Authorities can rely on a robust decision-making tool to strengthen their fight against the COVID-19 pandemic and future health risks. LAUSANNE, Switzerland, May 6, 2022 /PRNewswire/ -- The Swiss company SICPA, a world leader in identification, traceability and authentication technologies, and t...

2022-05-06 14:00 5037

Antengene to Participate in Three Upcoming Investor Conferences in May/June

CICC Healthcare Industry Forum 2022: May 9th to 12th BTIG Virtual China Biotech Day: June 1st Citi's 3rd Pan-Asia Regional Investor Conference 2022: June 8th to June 10th SHANGHAI and HONG KONG, May 6, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading inno...

2022-05-06 08:30 2463

World Lupus Federation Global Survey of People Living with Lupus finds 87% Report at Least One Major Organ Affected by the Disease

Survey Findings Released in Advance of World Lupus Day on May 10 WASHINGTON, May 6, 2022 /PRNewswire/ -- In a recent international survey, the World Lupus Federation found that 87% of the survey respondents living with lupus reported that the disease has impacted one or more major organs or organ...

2022-05-06 07:00 2276

Insilico Medicine expands synthetic lethality portfolio with the nomination of a preclinical candidate targeting MAT2A for the treatment of MTAP-deleted cancers

NEW YORK, May 6, 2022 /PRNewswire/ -- Insilico Medicine ("Insilico"), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced that the company has nominated a preclinical candidate (PCC) targeting methionine adenosyltransferase 2A (MAT2A) from AI-de...

2022-05-06 05:00 2482

Insilico Medicine expands synthetic lethality portfolio with nomination of a preclinical candidate targeting MAT2A for the treatment of MTAP-deleted cancers

NEW YORK, May 5, 2022 /PRNewswire/ -- Insilico Medicine ("Insilico"), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced that the company has nominated a preclinical candidate (PCC) targeting methionine adenosyltransferase 2A (MAT2A) from AI-de...

2022-05-05 23:00 2536

HOYA Vision Care Releases Results of First of its Kind Six-Year MiYOSMART Spectacle Lens Follow-up Clinical Study

Strong evidence shows continued long-term lens effectiveness in slowing myopia progression in children BANGKOK, May 5, 2022 /PRNewswire/ -- HOYA Vision Care, a leader in optical technology innovation, shared the results of asix-year follow-up clinical study on its award winning MiYOSMART spectac...

2022-05-05 22:12 2837

The Future Investment Initiative Institute announces its regional summit titled Inclusive ESG for Emerging Markets

* At the summit, FII institute will present a proprietary new inclusive ESG framework and scoring methodology developed for informing and accelerating ESG investments in emerging economies. RIYADH, Saudi Arabia, May 5, 2022 /PRNewswire/ -- The Future Investment Initiative (FII) Institute is hos...

2022-05-05 21:15 2174

TIKOMED and IQVIA announce a strategic collaboration for the development of TIKOMED's lead drug platform candidate ILB®

VIKEN, Sweden, May 5, 2022 /PRNewswire/ -- Today, Swedish biopharmaceutical company TikoMed AB and IQVIA announce a key strategic collaboration with the aim to accelerate the development of TikoMed's lead drug platform candidate ILB®, a broad-spectrum small molecule drug candidate with curative p...

2022-05-05 20:40 1411
1 ... 195196197198199200201 ... 551

Week's Top Stories